Dr. Fadi Kayali, MD
Claim this profileFlorida Cancer Specialists South / Sarah Cannon Research Institute
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
13 reported clinical trials
38 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
PD-L1 positive
2Non-Small Cell Lung Cancer
Stage IV
Stage III
PD-L1 positive
Affiliated Hospitals
Clinical Trials Fadi Kayali, MD is currently running
ONC-392 vs Chemotherapy
for Lung Cancer
This trial is testing gotistobart, a new drug that helps the immune system fight advanced lung cancer in patients who haven't responded to other treatments. It works by blocking a protein that allows cancer cells to hide from the immune system.
Recruiting2 awards Phase 310 criteria
Targeted Therapy
for Advanced Stage Cancer
The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*
Recruiting1 award Phase 29 criteria
More about Fadi Kayali, MD
Clinical Trial Related4 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Fadi Kayali, MD has experience with
- Placebo
- Abemaciclib
- Pembrolizumab
- Canakinumab
- ABL001
- NT-I7
Breakdown of trials Fadi Kayali, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Fadi Kayali, MD specialize in?
Fadi Kayali, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Fadi Kayali, MD currently recruiting for clinical trials?
Yes, Fadi Kayali, MD is currently recruiting for 3 clinical trials in Fort Myers Florida. If you're interested in participating, you should apply.
Are there any treatments that Fadi Kayali, MD has studied deeply?
Yes, Fadi Kayali, MD has studied treatments such as Placebo, Abemaciclib, Pembrolizumab.
What is the best way to schedule an appointment with Fadi Kayali, MD?
Apply for one of the trials that Fadi Kayali, MD is conducting.
What is the office address of Fadi Kayali, MD?
The office of Fadi Kayali, MD is located at: Florida Cancer Specialists South / Sarah Cannon Research Institute, Fort Myers, Florida 33908 United States. This is the address for their practice at the Florida Cancer Specialists South / Sarah Cannon Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.